TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
THRD

Third Harmonic Bio Inc.

Healthcare · Biotechnology

5.40$ +0.0% vs. previous close Closing price · As of: Jul 2, 2026

Statements

Balance Sheet

Third Harmonic Bio Inc. (THRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 25), "Total Assets" came in at 280 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet THRD
Line item Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25
– – – 129 – 114 305 299 291 286 282 278 271 266 304 295 280
8.3 – – 129 128 113 304 293 286 280 277 272 266 261 300 291 276
-8.3 – – 128 -128 113 300 289 282 278 274 269 263 255 296 285 272
8.3 – – 128 128 113 300 289 282 278 274 269 263 255 296 285 272
– – – – – – – 4.4 0.1 4.3 – – – – – – –
– – – 176 – 175 6.3 9.6 8.7 7.8 9.3 8.6 7.0 9.1 9.6 9.5 7.2
– – – 5.7 4.8 4.8 6.3 5.7 4.9 4.2 5.9 5.4 4.0 6.4 7.1 7.1 5.1
– – – – – – – 0.8 0.7 1.4 1.4 1.5 1.5 0.8 0.8 0.9 0.9
– – – 1.8 2.4 2.4 3.3 2.1 2.7 1.3 2.0 1.8 0.9 1.4 2.9 1.9 2.7
0.3 – – -47 123 -61 298 289 283 278 273 269 264 257 295 285 273
– – – -48 -64 -64 -72 -83 -92 -100 -107 -114 -122 -133 -147 -160 -176
3.9 3.9 26 26 26 39 9.1 39 39 40 40 40 40 41 41 41 45

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?